| P2093 | author name string | G J Sewell | |
| P2860 | cites work | Studies on the human pharmacokinetics of isophosphamide (NSC-109724) | Q28342614 |
| | Effect of the immunomodulator tilorone on the in vivo acetylation of procainamide in the rat. | Q34661389 |
| | Mechanisms of multidrug resistance in cancer treatment | Q35259390 |
| | Interactions between cytokines and cytotoxic drugs: putative molecular mechanisms in experimental hematology and oncology | Q35313011 |
| | Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review | Q36574740 |
| | alpha-Interferon and 5-fluorouracil: possible mechanisms of antitumor action | Q37501062 |
| | The clinical relevance of multidrug resistance | Q37607274 |
| | Substrate specificities and functions of the P450 cytochromes | Q38013182 |
| | Biologic response modifiers as adjuncts to other therapeutic modalities | Q38163358 |
| | Overview of preclinical and clinical studies of interferon alfa-2b in combination with cytotoxic drugs. | Q39659116 |
| | Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cells | Q41665366 |
| | Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line | Q41721690 |
| | Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid | Q42603971 |
| | Schedule-dependent inhibition of thymidylate synthase by 5-fluorouracil in gastric cancer | Q43455890 |
| | Induction and depression of cytochrome P-450-dependent mixed-function oxidase by a cloned consensus alpha-interferon (IFN-alpha CON1) in the hamster | Q44492161 |
| | Deactivation of cyclophosphamide (NSC-26271) metabolites by sulfhydryl compounds | Q44523073 |
| | A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study | Q44583571 |
| | MDR1 (P-glycoprotein) gene expression--implications for resistance modifier trials | Q45233164 |
| | The potentiation of barbiturate-induced narcosis by procarbazine | Q48398524 |
| | The effects of interleukin 2 and alpha-interferon administration on hepatic drug metabolism in mice | Q48890206 |
| | Decreased P-glycoprotein expression in multidrug-sensitive and -resistant human myeloma cells induced by the cytokine leukoregulin. | Q54259221 |
| | Rationale for and conduct of a phase I clinical trial with interferon alfa-2b plus doxorubicin. | Q54783215 |
| | Altered theophylline clearance during an influenza B outbreak | Q57114830 |
| | Microsomal activation of cyclophosphamide in vivo | Q68755862 |
| | In vitro activation of isophosphamide (NSC-109724), a new oxazaphosphorine, by rat liver microsomes | Q68772427 |
| | Augmentation of activity of cis-diamminedichloroplatinum(II) and mitomycin C by interferon in human malignant mesothelioma xenografts in nude mice | Q69012330 |
| | Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites | Q69035695 |
| | Positive interaction between interferon and bleomycin in vitro and in animal experimental models | Q69093044 |
| | Interferon effects upon fluorouracil metabolism by HL-60 cells | Q69734605 |
| | Clinical pharmacokinetics of cyclophosphamide | Q70146495 |
| | Perturbation of metabolism and disposition of cyclophosphamide by interferon and poly I:C, an interferon inducer, in mice | Q70201842 |
| | Modulation by a human interferon of antitumor effects of cyclophosphamide against a lymphosarcoma in hamsters | Q70816663 |
| | N-demethylation the antineoplastic agent4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide by rats and man | Q71495711 |
| | Some chemical and biochemical aspects of liver microsomal metabolism of tamoxifen | Q72588348 |
| P433 | issue | 1 | |
| P921 | main subject | multiple drug resistance | Q643839 |
| | chemotherapy | Q974135 |
| | drug resistance | Q12147416 |
| P304 | page(s) | 9-14 | |
| P577 | publication date | 1995-03-01 | |
| P1433 | published in | Medical Oncology | Q2152666 |
| P1476 | title | Interaction of alpha-interferon with chemotherapeutic agents: effects on cytotoxic drug metabolism and multiple drug resistance | |
| P478 | volume | 12 | |